宫颈癌诊断后异时性外阴癌、阴道癌和肛门癌的发病率及危险因素
这项回顾性研究分析1973至2013年监测、流行病学和最终结果项目数据,纳入79,050例宫颈癌患者。阴道癌20年累积发病率最高(0.57%),其次为外阴癌(0.33%)和肛门癌(0.16%,P<0.001)。多因素分析显示年龄增长与三种异时性癌症均相关,鳞状组织学和放疗与外阴癌相关,黑人种族与阴道癌相关。
要点
- 阴道癌20年累积发病率0.57%,外阴癌0.33%,肛门癌0.16%(P<0.001)。
- 外阴癌与年龄增长、鳞状组织学(HR 2.64)和放疗(HR 2.52)相关。
- 阴道癌与年龄增长和黑人种族(HR 1.73)相关,肛门癌仅与年龄增长相关。
核心结论
- 宫颈癌诊断后肛门生殖器癌症虽然罕见,但发病率随时间持续增加;作者认为治疗后长期随访和监测以发现这些异时性恶性肿瘤是合理的,尤其在高危因素者中。
研究设计与样本
- 回顾性研究,分析1973至2013年监测、流行病学和最终结果项目数据,纳入79,050例宫颈癌患者,评估异时性外阴癌、阴道癌和肛门癌的累积发病率,并进行多因素分析确定独立危险因素。
主要发现
- 阴道癌20年累积发病率0.57%,外阴癌0.33%,肛门癌0.16%(P<0.001)。
- 阴道癌中位诊断时间5.4年,外阴癌6.5年,肛门癌13.5年。
- 多因素分析:外阴癌与年龄增长(HR 1.04,95%CI 1.02-1.05,P<0.001)、鳞状组织学(HR 2.64,95%CI 1.38-5.05,P=0.003)和放疗(HR 2.52,95%CI 1.66-3.84,P<0.001)相关。
- 阴道癌与年龄增长(HR 1.03,95%CI 1.02-1.04,P<0.001)和黑人种族(HR 1.73,95%CI 1.20-2.48,P=0.003)相关;肛门癌与年龄增长(HR 1.03,95%CI 1.01-1.05,P=0.017)相关。
- 异时性癌症总体生存率较差:5年生存率外阴癌46.3%、阴道癌43.0%、肛门癌47.5%。
临床怎么用
- 作者认为宫颈癌治疗后长期随访和监测以发现这些异时性恶性肿瘤是合理的,尤其在高危因素者中。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine incidences and risk factors for metachronous vulvar, vaginal, and anal malignancies after a cervical cancer diagnosis. METHODS: This is a retrospective study examining data from the Surveillance, Epidemiology, and End Result Program between 1973 and 2013. Cumulative incidences of vulvar, vaginal, and anal cancers after the diagnosis of cervical cancer were assessed (n = 79,050). Multivariable analysis was performed to determine independent risk factors for these metachronous cancers. RESULTS: Vaginal cancer (20-year cumulative incidence, 0.57%) was the most common type of metachronous malignancy, followed by vulvar cancer (0.33%), and anal cancer (0.16%, P < 0.001). Median time to diagnosis was 5.4 years for vaginal cancer, 6.5 years for vulvar cancer, and 13.5 years for anal cancer. On multivariable analysis, metachronous vulvar cancer was associated with older age (hazard ratio [HR] per year 1.04, 95% confidence interval [CI] 1.02-1.05, P < 0.001), squamous histology (HR 2.64, 95%CI 1.38-5.05, P = 0.003), and radiotherapy use (HR 2.52, 95%CI 1.66-3.84, P < 0.001); metachronous vaginal cancer was associated with older age (HR per year 1.03, 95%CI 1.02-1.04, P < 0.001) and Black race (HR 1.73, 95%CI 1.20-2.48, P = 0.003); and metachronous anal cancer was associated with older age (HR 1.03, 95%CI 1.01-1.05, P = 0.017). Overall survival of metachronous cancer was poor (5-year rates: 46.3% for vulvar, 43.0% for vaginal, and 47.5% for anal cancer, respectively). CONCLUSION: Although rare, the rate of ano-genital cancers continues to increase over time after a cervical cancer diagnosis. Long-term follow-up and surveillance after cervical cancer treatment is therefore reasonable to detect these metachronous malignancies, particularly in those with risk factors.
引用
- Matsuo K, Blake EA, Machida H, et al. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis. Gynecol Oncol. 2018. PMID: 30054103. doi:10.1016/j.ygyno.2018.07.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。